New User:

Forgot your password?

Stock Market & Financial Investment News

News For A;CBS;ELLI;KEG;LOGM;VVC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 12, 2015
08:47 EDTCBSCBS sell-off overdone, valuation compelling, says RBC Capital
Subscribe for More Information
08:06 EDTALabCorp to offer new PD-L1 test for Bristol-Myers' Opdivo
Subscribe for More Information
05:17 EDTADasko announces FDA approval of Opdivo for patients with non-squamous NSCLC
Subscribe for More Information
October 9, 2015
18:31 EDTAQuest Diagnostics introduces Dako's PD-L1 companion diagnostic for OPDIVO
Subscribe for More Information
15:23 EDTADako announces FDA approval of new lung test for cancer patients
Subscribe for More Information
08:20 EDTCBSTop quality video content to outperform, says Pacific Crest
Pacific Crest predicts that companies with top quality video content will outperform, taking share from those with mid-range content. It identifies this trend as positive for Netflix, AMC Networks (AMCX), Time Warner (TWX), Disney (DIS), CBS (CBS), and 21st Century Fox (FOXA). According to the firm, this trend is negative for Viacom (VIAB), Scripps Networks (SNI), Discovery (DISCA), and Comcast (CMCSA)
08:02 EDTLOGMLogMeln acquires LastPass for $110M in cash
LogMeIn announced that it has agreed to acquire LastPass. A high growth business with millions of loyal users and an award winning product line, LastPass will immediately bolster LogMeIn's position in the multi-billion dollar identity and access management market, while accelerating one of the company's key strategic growth initiatives. The deal is expected to close in the coming weeks. Under the terms of the transaction, LogMeIn will pay $110M in cash upon close for all outstanding equity interests in LastPass, with up to an additional $15M in cash payable in contingent payments which are expected to be paid to equity holders and key employees of LastPass upon the achievement of certain milestone and retention targets over the two-year period following the closing of the transaction.
October 7, 2015
15:14 EDTCBSAmazon considering possible online service for live TV, Bloomberg says
Subscribe for More Information
15:00 EDTCBSAmazon exploring potential online TV service, Bloomberg says
Amazon (AMZN) is said to have reached out to CBS (CBS) and Comcast's (CMCSA) NBCUniversal about online TV, according to Bloomberg.
09:46 EDTCBSConflict grows at Viacom board around chairman's health, WSJ says
Drama in the boardroom at Viacom (VIA) is brewing amid questions about the health of executive chairman Sumner Redstone, the Wall Street Journal says. Redstone has roughly an 80% voting stake in the company, the report says. Redstone's daughter, Shari Redstone, and Viacom CEO Philippe Dauman both have claims to a major position in Viacom following the death of Sumner, the report says. Redstone said in an emailed statement Tuesday that he established a trust decades ago to ensure that his controlling stake in Viacom and CBS (CBS) would be "professionally managed for the benefit of all shareholders" after he is gone, the report says. Reference Link
October 6, 2015
07:23 EDTAAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information
October 5, 2015
05:29 EDTADako announces FDA approval of new companion diagnostic assay
Subscribe for More Information
October 2, 2015
15:57 EDTALabCorp to offer PD-L1 companion diagnostic
Subscribe for More Information
15:43 EDTAQuest Diagnostics introduces Dako's PD-L1 companion diagnostic for KEYTRUDA
Subscribe for More Information
15:25 EDTAAgilent's Dako confirms FDA approval of NSCLC diagnostic
Dako, an Agilent Technologies (A) company and a worldwide provider of cancer diagnostics, announced the FDA approval of a new companion diagnostic assay that can reveal whether a patient with advanced non-small cell lung cancer, or NSCLC, is likely to respond to a new form of treatment. The approval of PD-L1 IHC 22C3 pharmDx strengthens Dako's portfolio of companion diagnostics and the company's leadership position in developing and commercializing companion diagnostic products. Dako developed PD-L1 IHC 22C3 pharmDx in partnership with Merck (MRK), maker of the anti-PD-1 therapy Keytruda. The FDA approved PD-L1 IHC 22C3 pharmDx for use in the United States. Dako hopes to gain regulatory approval for the new diagnostic in Canada, Europe and other jurisdictions next year.
October 1, 2015
16:05 EDTCBSRentrak says all CBS TV owned & operated stations are Rentrak subscribers
Subscribe for More Information
12:54 EDTCBSOptions with increasing call volume
Subscribe for More Information
09:29 EDTCBSAmazon, CBS announce multi-year, multi-series content licensing agreement
Subscribe for More Information
September 29, 2015
13:09 EDTCBSGoogle to bring Showtime, NBA content to Chromecast
Subscribe for More Information
09:29 EDTKEGDeutsche Bank to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use